Two of these well-known coactivators are the histone acetyltransferases p300 and CBP (CREB binding protein) that show elevated expression in advanced PCa and have oncogenic potential (Debes et al. 2003, Comuzzi et al. 2004). The gene discussed is EP300; the disease is posterior cortical atrophy.